Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Australie (1)
Advocacy (policy advocacy, lobbying)
Musculoskeletal/Multiple Sclerosis (MS) (1)
Pharmaceutical Company (9)
Payers (usually governmental or public bodies, reimbursement)
Roles and responsibilities
Clinical study phase I